Position
SIMPLEX TRADING, LLC in Cytek Biosciences, Inc.
Back to the book · All holders of CTKB
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$1.36K$5.05 → $4.37
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 2K | $10.1K | — | — | — | 0.0% |
| Q1 2026 | 3.23K | $14.1K | $4.37 | −$1.36K | $5.34K | 0.0% |